Our random forest biomarker discovery pinpointed three novel biomarker genes not previously associated with BCNHL, YES1, FERMT2, and FAM98B, which show high fidelity in predicting lymphoma presence based on transcriptional levels in B-cells. Here, TSLIG3B is linked to lymphoma.